These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31159615)

  • 1. Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell line.
    Yalcin S
    Pharm Dev Technol; 2019 Oct; 24(8):1032-1037. PubMed ID: 31159615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-222 and miR-29a contribute to the drug-resistance of breast cancer cells.
    Zhong S; Li W; Chen Z; Xu J; Zhao J
    Gene; 2013 Nov; 531(1):8-14. PubMed ID: 23994196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-29a suppresses MCF-7 cell growth by downregulating tumor necrosis factor receptor 1.
    Zhao Y; Yang F; Li W; Xu C; Li L; Chen L; Liu Y; Sun P
    Tumour Biol; 2017 Feb; 39(2):1010428317692264. PubMed ID: 28222663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
    Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
    Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Suppression of Disulfide Cross-Linking Micelles Nanocarriers Loaded miR-145 Delivering System via Down-Regulation of MYC and FSCN1 in Colon Cancer Cells.
    Zhai J; Zhu Y; Liu J; An J; Yu Y; Li Y; Fan Y
    J Biomed Nanotechnol; 2020 Aug; 16(8):1183-1195. PubMed ID: 33397549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
    Yuan LL; Li L; Liu JN; Mei J; Lei CJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose rate affects the radiosensitization of MCF-7 and HeLa cell lines to X-rays induced by dextran-coated iron oxide nanoparticles.
    Khoshgard K; Kiani P; Haghparast A; Hosseinzadeh L; Eivazi MT
    Int J Radiat Biol; 2017 Aug; 93(8):757-763. PubMed ID: 28452253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-Benzoporphyrin Derivative (BPD) Coated Superparamagnetic Iron Oxide Nanoparticle (SPION) Micelles for T
    Yan L; Luo L; Amirshaghaghi A; Miller J; Meng C; You T; Busch TM; Tsourkas A; Cheng Z
    Bioconjug Chem; 2019 Nov; 30(11):2974-2981. PubMed ID: 31661959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
    Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
    Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of miR-155 in MCF-7 breast cancer cell line by gold nanoparticles functionalized with antagomir and AS1411 aptamer.
    Kardani A; Yaghoobi H; Alibakhshi A; Khatami M
    J Cell Physiol; 2020 Oct; 235(10):6887-6895. PubMed ID: 32003016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextran-Coated Iron Oxide Nanoparticles as Biomimetic Catalysts for Localized and pH-Activated Biofilm Disruption.
    Naha PC; Liu Y; Hwang G; Huang Y; Gubara S; Jonnakuti V; Simon-Soro A; Kim D; Gao L; Koo H; Cormode DP
    ACS Nano; 2019 May; 13(5):4960-4971. PubMed ID: 30642159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory role of Mir-29 in growth of breast cancer cells.
    Wu Z; Huang X; Huang X; Zou Q; Guo Y
    J Exp Clin Cancer Res; 2013 Dec; 32(1):98. PubMed ID: 24289849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles.
    Shaterabadi Z; Nabiyouni G; Soleymani M
    Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():947-956. PubMed ID: 28415550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of miR-125b/miR-182 in human breast cancer cells.
    Hossainzadeh S; Ranji N; Naderi Sohi A; Najafi F
    J Cell Physiol; 2019 Dec; 234(12):22285-22298. PubMed ID: 31073992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2.
    Wu Y; Shi W; Tang T; Wang Y; Yin X; Chen Y; Zhang Y; Xing Y; Shen Y; Xia T; Guo C; Pan Y; Jin L
    Cell Death Dis; 2019 Feb; 10(3):176. PubMed ID: 30792382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.
    Kaban K; Salva E; Akbuga J
    Nucleic Acid Ther; 2017 Feb; 27(1):45-55. PubMed ID: 27763825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of dextran-coated iron oxide nanoparticles in enhancing the radiosensitivity of cancerous cells in radiotherapy with high-energy electron beams.
    Rezaei M; Khoshgard K; Hosseinzadeh L; Haghparast A; Eivazi MT
    J Cancer Res Ther; 2019; 15(6):1352-1358. PubMed ID: 31898672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-29a regulated ER-positive breast cancer cell growth and invasion and is involved in the insulin signaling pathway.
    Li ZH; Xiong QY; Xu L; Duan P; Yang QO; Zhou P; Tu JH
    Oncotarget; 2017 May; 8(20):32566-32575. PubMed ID: 28427228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy.
    Tassa C; Shaw SY; Weissleder R
    Acc Chem Res; 2011 Oct; 44(10):842-52. PubMed ID: 21661727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.